Oral labetalol in the management of stable angina pectoris in normotensive patients.
The efficacy of labetalol, an alpha and beta receptor antagonist, was evaluated in 12 normotensive patients with stable angina pectoris in a single blind dose ranging study. After a two week period of placebo treatment, labetalol was given in doses of 100, 150, 200, and 300 mg twice daily, each for...
Uloženo v:
| Vydáno v: | Br Heart J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
1985
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481721/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3917674/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.53.1.53 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|